These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 10342984)

  • 1. The FDA's regulation of pharmaceutical communications in the context of managed care: a suggested approach.
    Kuhlik BN
    Food Drug Law J; 1995; 50(1):23-48. PubMed ID: 10342984
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeting formulary pull-through strategies: the role of pharmaceutical manufacturers.
    Navarro RP
    Manag Care Interface; 1999 May; 12(5):84-6. PubMed ID: 10537482
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA considers effects of managed care marketplace on drug promotional practices.
    Wechsler J
    Formulary; 1995 Dec; 30(12):840-1. PubMed ID: 10153083
    [No Abstract]   [Full Text] [Related]  

  • 4. The response to health care reform by the pharmaceutical industry.
    Krulwich AS
    Food Drug Law J; 1995; 50(1):1-22. PubMed ID: 10342983
    [No Abstract]   [Full Text] [Related]  

  • 5. Managed care pharmacy 101: learning from the students.
    Penna P
    Manag Care Interface; 2005 Apr; 18(4):28, 31. PubMed ID: 15889760
    [No Abstract]   [Full Text] [Related]  

  • 6. The potential for self-interested behavior by pharmaceutical manufacturers through vertical integration with pharmacy benefit managers: the need for a new regulatory approach.
    Mitchell EL
    Food Drug Law J; 1999; 54(1):151-83. PubMed ID: 11758556
    [No Abstract]   [Full Text] [Related]  

  • 7. Changing the marketing message.
    Navarro RP
    Med Interface; 1995 Jun; 8(6):83-5. PubMed ID: 10142946
    [No Abstract]   [Full Text] [Related]  

  • 8. The FDA's accelerated approval process: does the pharmaceutical industry have adequate incentives for self-regulation?
    Orlando VI
    Am J Law Med; 1999; 25(4):543-68. PubMed ID: 10629734
    [No Abstract]   [Full Text] [Related]  

  • 9. The Patient's Bill of Rights and the pharmacy benefit.
    Penna PM
    Manag Care Interface; 2000 Oct; 13(10):80-1. PubMed ID: 11155654
    [No Abstract]   [Full Text] [Related]  

  • 10. Injectable drugs: the new frontier in pharmacy management.
    Rodgers JR
    Am J Manag Care; 2003 Jun; Suppl Decision Maker News():5-8. PubMed ID: 12866365
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmaceuticals issue brief: managed care drug formularies: year end report-2003.
    MacEachern L
    Issue Brief Health Policy Track Serv; 2003 Dec; ():1-8. PubMed ID: 14969259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical industry and payer partnerships: legal update.
    Goldstein WC
    Manag Care; 2001 Sep; 10(9 Suppl):5-6; discussion 9-12. PubMed ID: 11729439
    [No Abstract]   [Full Text] [Related]  

  • 13. Reframing the pharmaceutical manufacturer/health plan relationship in managed care.
    Studin I
    Manag Care; 2002 Feb; 11(2):46, 49-54. PubMed ID: 11904913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications for managed care organizations of the Merck and Medco consent.
    Pollard MR; Tilson HH
    Med Interface; 1996 Mar; 9(3):60-2. PubMed ID: 10184511
    [No Abstract]   [Full Text] [Related]  

  • 15. Disease management and antikickback regulations.
    Kozma CM
    Manag Care Interface; 2003 Dec; 16(12):34-5. PubMed ID: 14750462
    [No Abstract]   [Full Text] [Related]  

  • 16. Legislative challenges facing managed care pharmacy.
    Epstein L
    Manag Care Interface; 1997 Oct; 10(10):92-4, 98. PubMed ID: 10174422
    [No Abstract]   [Full Text] [Related]  

  • 17. Regulatory and legislative challenges facing managed care.
    Giaquinta D
    Manag Care Interface; 2000 Jul; 13(7):47-9. PubMed ID: 11183928
    [No Abstract]   [Full Text] [Related]  

  • 18. Too big? Caremark, AdvancePCS getting close look from feds.
    Becker C
    Mod Healthc; 2004 Jan; 34(2):14, 16. PubMed ID: 14959629
    [No Abstract]   [Full Text] [Related]  

  • 19. Legalized importation of Canadian prescription drugs: short-term solution to a long-term problem.
    Teufel AT
    J Contemp Health Law Policy; 2006; 22(2):383-408. PubMed ID: 17117702
    [No Abstract]   [Full Text] [Related]  

  • 20. A whole new world?: pharmaceutical responses to the managed care revolution.
    Balto DA
    Food Drug Law J; 1997; 52(1):83-98. PubMed ID: 10346712
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.